Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
European Journal of Radiology Open
|
September 12, 2022
Feasibility of using CT radiomic signatures for predicting CD8-T cell infiltration and PD-L1 expression in renal cell carcinoma
Bino Varghese, Steven Cen, Haris Zahoor, et al.
Plos One
|
August 23, 2014
The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder
Xiuqing Li, Wesley W Choi, Rui Yan, et al.
Blood Neoplasia
|
January 15, 2026
Tisagenlecleucel in combination with ibrutinib in adults with relapsed and/or refractory large B-cell lymphomas
Julio C Chavez, Ellen Napier, Attilio Bondanza, et al.
Perioperative Medicine (London, England)
|
March 3, 2026
The feasibility of implementing and evaluating individualised digital prehabilitation prior to major elective surgery in adults aged ≥ 50 years: the PreActiv intervention
Annabelle Emery, Rebecca Allam, David Quinn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2019
Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib
Gary A Ulaner, Cristina Saura, Sarina A Piha-Paul, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 2, 2025
Phase Ib Study of Enzalutamide with Venetoclax in Patients with Metastatic Castration-Resistant Prostate Cancer
Stuthi Perimbeti, Anmbreen Jamroze, Dharmesh Gopalakrishnan, et al.
Cancer Chemotherapy and Pharmacology
|
November 28, 2025
Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer
Stuthi Perimbeti, Anmbreen Jamroze, Dharmesh Gopalakrishnan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2022
EphrinB2 Inhibition and Pembrolizumab in Metastatic Urothelial Carcinoma
Sarmad Sadeghi, David Quinn, Tanya Dorff, et al.
JAMIA Open
|
November 21, 2025
The AIR·MS data platform for artificial intelligence in healthcare
Pablo Guerrero, Morten Ernebjerg, Thomas Holst, et al.
Blood Advances
|
March 17, 2026
Phase 1b study of ABBV-744, a novel, selective BET inhibitor, as monotherapy in patients with myelofibrosis
John O Mascarenhas, Laura Maria Fogliatto, Steven D Green, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
European Journal of Radiology Open
|
September 12, 2022
Feasibility of using CT radiomic signatures for predicting CD8-T cell infiltration and PD-L1 expression in renal cell carcinoma
Bino Varghese, Steven Cen, Haris Zahoor, et al.
Plos One
|
August 23, 2014
The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder
Xiuqing Li, Wesley W Choi, Rui Yan, et al.
Blood Neoplasia
|
January 15, 2026
Tisagenlecleucel in combination with ibrutinib in adults with relapsed and/or refractory large B-cell lymphomas
Julio C Chavez, Ellen Napier, Attilio Bondanza, et al.
Perioperative Medicine (London, England)
|
March 3, 2026
The feasibility of implementing and evaluating individualised digital prehabilitation prior to major elective surgery in adults aged ≥ 50 years: the PreActiv intervention
Annabelle Emery, Rebecca Allam, David Quinn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2019
Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib
Gary A Ulaner, Cristina Saura, Sarina A Piha-Paul, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 2, 2025
Phase Ib Study of Enzalutamide with Venetoclax in Patients with Metastatic Castration-Resistant Prostate Cancer
Stuthi Perimbeti, Anmbreen Jamroze, Dharmesh Gopalakrishnan, et al.
Cancer Chemotherapy and Pharmacology
|
November 28, 2025
Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer
Stuthi Perimbeti, Anmbreen Jamroze, Dharmesh Gopalakrishnan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2022
EphrinB2 Inhibition and Pembrolizumab in Metastatic Urothelial Carcinoma
Sarmad Sadeghi, David Quinn, Tanya Dorff, et al.
JAMIA Open
|
November 21, 2025
The AIR·MS data platform for artificial intelligence in healthcare
Pablo Guerrero, Morten Ernebjerg, Thomas Holst, et al.
Blood Advances
|
March 17, 2026
Phase 1b study of ABBV-744, a novel, selective BET inhibitor, as monotherapy in patients with myelofibrosis
John O Mascarenhas, Laura Maria Fogliatto, Steven D Green, et al.
Page
of 8